The Uromigos
The Uromigos
Advertisement
The UromigosThe Uromigos | October 28, 2024
Returning guests Bertrand Tombal and Silke Gillessen join the podcast to dive into data from the 2024 APCCC.
Listen Now
The UromigosThe Uromigos | October 23, 2024
Special guest Bertrand Tombal of Manchester Cancer Research Centre focuses on the historic and current data of AR inhibition
The UromigosThe Uromigos | October 16, 2024
Christopher Cutie from J and J joins the show to discuss the SUNRISE bladder program.
The UromigosUromigos Live 2024 | October 15, 2024
Listen to the podcast format of the kidney cancer panel on IO after IO therapy from Uromigos Live 2024.
The UromigosThe Uromigos | September 30, 2024
Drs. Maite Bourlon, Elena Castro and Cristina Suarez cover the UC topics discussed on day 1 of Uromigos Live 2024.
The UromigosUromigos Live 2024 | September 30, 2024
Listen to the podcast format of the peri-operative therapy in bladder cancer panel from Uromigos Live 2024.
The UromigosUromigos Live 2024 | September 28, 2024
Listen to the podcast format of the kidney cancer panel on TKI vs Ipi/Nivo vs IO/TKI from Uromigos Live 2024.
The UromigosUromigos Live 2024 | September 28, 2024
Listen to the podcast format of the panel on radioligand data in prostate cancer from Uromigos Live 2024.
The UromigosUromigos Live 2024 | September 28, 2024
Listen to the podcast format of the panel on T cell directed therapy in prostate cancer from Uromigos Live 2024.
The UromigosUromigos Live 2024 | September 28, 2024
Listen to the podcast format of the panel on on emerging ADC data in bladder cancer from Uromigos Live 2024.
The UromigosThe Uromigos | September 24, 2024
Tom and Brian finish discussing bladder and kidney cancer highlights from ESMO 2024.
The UromigosThe Uromigos | September 23, 2024
Silke joins us to discuss ESMO 2024 highlights, then the birds start singing....
The UromigosThe Uromigos | September 19, 2024
Fresh off the Presidential session address, Tom discusses his data with Petros commenting.
The UromigosThe Uromigos | September 16, 2024
Uromigos Japan with Yuji, Hiroshi and Nobu is formed and discuss Hiroshi's ESMO data.
The UromigosThe Uromigos | September 17, 2024
Arun Azad describes this randomised phase II study of sequential 177Lu-PSMA-617 and docetaxel vs. docetaxel in mHSPC.
The UromigosThe Uromigos | September 17, 2024
Matt Galsky describes his ESMO 2024 abstract of disitimab vedotin + pembrolizumab in bladder cancer.
The UromigosThe Uromigos | September 17, 2024
Silke Gillessen joins us to discuss her Presidential session from ESMO 2024.
The UromigosThe Uromigos | October 14, 2024
Lothar Bergmann describes this investigator-initiated trial of Ipi/Nivo vs SOC in Non-clear Cell RCC.
The UromigosThe Uromigos | September 23, 2024
Brad McGregor joins Brian and Tom to discuss a new HIF inhibitor, NKT2152, and preliminary data in RCC.
The UromigosThe Uromigos | September 23, 2024
Katy Beckermann discusses the TiNivo-2 study presented at ESMO 2024.
Advertisement
Advertisement
Advertisement